How The Wolverine Stack works
The Wolverine Stack pairs BPC 157's angiogenic, VEGF-driven local repair with TB500's actin-mediated cell migration. One builds the blood supply into the injury, the other moves the repair cells through it — which is why the combination is the default for stubborn tendon and ligament work.
Reported benefits
- Accelerated recovery from soft-tissue injury
- Local and systemic repair coverage in one protocol
- Improved joint mobility alongside structural healing
- Reduced inflammation and scar formation
Reported side effects
Effects reported in published trials, case reports or post-market surveillance. Individual response varies; this list is educational and not exhaustive.
- Combined injection-site reactions from both components
- Fatigue or head-rush in the first week
- Stacking increases uncertainty — no combination safety data
Serious or rare signals
- Both components are WADA-prohibited and unapproved
Regulatory status & sources
Blends have no regulatory approval and no combination trials; each component is research-use only.
Safety note
The Wolverine Stack is presented here for research and educational purposes only. It is not offered for human consumption and nothing on this page is medical advice or a dosing protocol. Read the full safety and disclaimer page.